Cargando…
LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565085/ https://www.ncbi.nlm.nih.gov/pubmed/26352157 http://dx.doi.org/10.1186/2050-6511-16-S1-A1 |
| _version_ | 1782389553037836288 |
|---|---|
| author | Lefkowitz, Martin P |
| author_facet | Lefkowitz, Martin P |
| author_sort | Lefkowitz, Martin P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4565085 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45650852015-09-18 LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure Lefkowitz, Martin P BMC Pharmacol Toxicol Meeting Abstract BioMed Central 2015-09-02 /pmc/articles/PMC4565085/ /pubmed/26352157 http://dx.doi.org/10.1186/2050-6511-16-S1-A1 Text en Copyright © 2015 Lefkowitz http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract Lefkowitz, Martin P LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title | LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title_full | LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title_fullStr | LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title_full_unstemmed | LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title_short | LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure |
| title_sort | lcz696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (arni): clinical development in heart failure |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565085/ https://www.ncbi.nlm.nih.gov/pubmed/26352157 http://dx.doi.org/10.1186/2050-6511-16-S1-A1 |
| work_keys_str_mv | AT lefkowitzmartinp lcz696sacubitrilvalsartananangiotensinreceptorneprilysininhibitorarniclinicaldevelopmentinheartfailure |